These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 17925065

  • 1. Part III: Location of asthma inflammation and the distal airways: clinical implications.
    Kraft M.
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S21-7. PubMed ID: 17925065
    [Abstract] [Full Text] [Related]

  • 2. Small airway asthma therapy, challenges, and the future.
    Casale TB.
    Postgrad Med; 2003 Feb; 113(2 Suppl):15-20. PubMed ID: 19667625
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic significance of distal airway inflammation in asthma.
    Martin RJ.
    J Allergy Clin Immunol; 2002 Feb; 109(2 Suppl):S447-60. PubMed ID: 11842317
    [Abstract] [Full Text] [Related]

  • 4. Lung function changes in asthmatic children treated with HFA-BDP.
    Eid N, Morton R.
    Pediatr Pulmonol; 2011 Sep; 46(9):837-41. PubMed ID: 21465678
    [Abstract] [Full Text] [Related]

  • 5. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [Abstract] [Full Text] [Related]

  • 6. Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma.
    Zeidler M, Corren J.
    Treat Respir Med; 2004 Jul; 3(1):35-44. PubMed ID: 15174892
    [Abstract] [Full Text] [Related]

  • 7. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
    Lipworth BJ, Jackson CM.
    Respir Med; 2000 Feb; 94(2):177; author reply 179-80. PubMed ID: 10714427
    [No Abstract] [Full Text] [Related]

  • 8. The role of small airway inflammation in asthma.
    Tashkin DP.
    Allergy Asthma Proc; 2002 Feb; 23(4):233-42. PubMed ID: 12221892
    [Abstract] [Full Text] [Related]

  • 9. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
    Ohbayashi H, Adachi M, Ichinose M, Ohta K, Kokubu F, Sano Y, Tamura G, Tohda Y, Hirata K, Yasuba H.
    Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
    [Abstract] [Full Text] [Related]

  • 10. Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma.
    Menzies D, Nair A, Hopkinson P, McFarlane L, Lipworth BJ.
    Allergy; 2007 Jun; 62(6):661-7. PubMed ID: 17508971
    [Abstract] [Full Text] [Related]

  • 11. Use of inhaled corticosteroids in pediatric asthma.
    Bisgaard H.
    Pediatr Pulmonol Suppl; 1997 Sep; 15():27-33. PubMed ID: 9316099
    [Abstract] [Full Text] [Related]

  • 12. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
    Boulet LP.
    Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
    [Abstract] [Full Text] [Related]

  • 13. Targeting the small airways asthma phenotype: if we can reach it, should we treat it?
    Lipworth B.
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):233-9. PubMed ID: 23535085
    [Abstract] [Full Text] [Related]

  • 14. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [Abstract] [Full Text] [Related]

  • 15. Inhaled corticosteroid therapy in newly detected mild asthma.
    O'Byrne PM.
    Drugs; 1999 Jul; 58 Suppl 4():17-24; discussion 52. PubMed ID: 10711855
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A, Richter A, Oster H, Criée CP.
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [Abstract] [Full Text] [Related]

  • 17. Targeting small airways in asthma: improvement in clinical benefit?
    Ulrik CS, Lange P.
    Clin Respir J; 2011 Jul; 5(3):125-30. PubMed ID: 21106032
    [Abstract] [Full Text] [Related]

  • 18. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
    Ederle K, Multicentre Study Group.
    Eur Rev Med Pharmacol Sci; 2003 Jul; 7(2):45-55. PubMed ID: 12911119
    [Abstract] [Full Text] [Related]

  • 19. Air trapping in mild and moderate asthma: effect of inhaled corticosteroids.
    Tunon-de-Lara JM, Laurent F, Giraud V, Perez T, Aguilaniu B, Meziane H, Basset-Merle A, Chanez P.
    J Allergy Clin Immunol; 2007 Mar; 119(3):583-90. PubMed ID: 17204317
    [Abstract] [Full Text] [Related]

  • 20. Extrafine aerosols and peripheral airway function in asthma.
    Merkus PJ, Gappa M, Janssens H, Pijnenburg MW.
    Pediatr Pulmonol; 2012 Jun; 47(6):626; author reply 627. PubMed ID: 22081582
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.